S.A. DE C.V.;REPRESENTACIONES E INVESTIGACIONES MEDICAS
发明人:
GARCÍA ARMENTA, MARÍA ELENA,SANTOS MURILLO, JOSEFINA,ALVAREZ OCHOA, VÍCTOR GUILLERMO
申请号：
PL08778967
公开号：
PL2179732T3
申请日:
2008.06.16
申请国别(地区):
PL
年份:
2014
代理人:
摘要：
The present invention refers to a pharmaceutical composition comprising a synergic combination of an enzyme HMG-CoA reductase inhibiting agent, such as active principle atorvastatin and a gastrointestinal lipase enzyme inhibiting agent, such as active principle orlistat, which are formulated in a single dosage unit to be administered orally, for treatment and control of diseases such as dyslipidemias (hypercholesterolemia and hypertriglyceridemia) and other related conditions.
